14-day PCAB-based High-dose Dual Therapy and14-day PCAB-based Triple Therapy vs 14-day PPI-based Reverse Hybrid Therapy

NCT05191888 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

906

Enrollment

OTHER

Sponsor class

Conditions

Helicobacter Pylori Eradication

Interventions

DRUG: Vonoprazan and Amoxicillin
DRUG: Vonoprazan, Amoxicillin and Clarithromycin
DRUG: Rabeprazole, Amoxicillin, Clarithromycin and Metronidazole

Sponsor

Kaohsiung Medical University